Plasma Proteome Profiling Reveals Inflammation Markers and Tafamidis Effects in V30M Transthyretin Polyneuropathy.

In both non-responder and responder groups, spectral counts had decreased after 24 months of tafamidis treatment compared to the baseline at t 0 , although this trend did not reach statistical significance ( p = 0.0503 and p = 0.1553, respectively) ( Figure 5 C).

also in 111,027 other papers